Mixed Results for Bone Marrow–Derived Cell Therapy for Ischemic Heart Disease

Q: What is the clinical evidence from this study?

Population: Ischemic Heart Disease. Intervention: Bone Marrow–Derived Cell Therapy.

Q: What does this research mean for the field?

Bone marrow-derived cell therapy produces mixed therapeutic efficacy in the treatment of ischemic heart disease. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

Eduardo Marbán; Konstantinos Malliaras

doi:10.1001/jama.2012.64751

November 5, 2012JAMA

Mixed Results for Bone Marrow–Derived Cell Therapy for Ischemic Heart Disease

View at Publisher

Ask AI

Bookmark

Share

Key result

Bone marrow-derived cell therapy yields mixed clinical results in ischemic heart disease.

PICO

P

Population

Ischemic Heart Disease

I

Intervention / Comparator

Bone Marrow–Derived Cell Therapy

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Marbán et al. (2012) studied Ischemic Heart Disease. Bone Marrow–Derived Cell Therapy was evaluated.

synapsesocial.com/papers/6a71b74126770c2b8de134d0 https://doi.org/10.1001/jama.2012.64751

View at Publisher

Ask AI

Bookmark

Share

Mixed Results for Bone Marrow–Derived Cell Therapy for Ischemic Heart Disease

PICO

Abstract

Discussion

Cite This Study

Mixed Results for Bone Marrow–Derived Cell Therapy for Ischemic Heart Disease

PICO

Abstract

Discussion

Cite This Study

Keep reading

More from JAMA

Keep reading

More from JAMA